Status:

ACTIVE_NOT_RECRUITING

Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction

Lead Sponsor:

University of North Carolina, Chapel Hill

Conditions:

Long Haul COVID-19

Post-Acute COVID-19 Syndrome

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The goal of this pilot study is to assess the feasibility and impact of using sodium citrate nasal spray as an adjunct to olfactory retraining in participants with long-term post-COVID-19 olfactory dy...

Detailed Description

Background: Loss of sense of smell is a hallmark of COVID-19 infection. While about 80% of post-COVID olfactory dysfunction (OD) will experience some spontaneous recovery within 2 months of initial in...

Eligibility Criteria

Inclusion

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male and female, ages greater than or equal to 18 years.
  • Patients with persistent olfactory dysfunction originating at the time of a confirmed COVID-19 positive test occurring greater than 3 months ago.
  • Ability to use nasal spray and be willing to adhere to the nasal spray and olfactory training regimen

Exclusion

  • Treatment with another investigational drug or other intervention for olfactory dysfunction within the prior three months.
  • Current smoker or inhaled tobacco use within the last three months.
  • History of chronic sinusitis or nasal polyps.
  • History of olfactory dysfunction following head trauma.
  • History of sinus or skull base surgery.
  • History of persistent olfactory dysfunction related to any other prior cause other than COVID-19 infection.
  • Congenital anosmia.
  • Inability to return to UNC Health for follow-up.

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06204432

Start Date

December 1 2023

End Date

December 1 2025

Last Update

February 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599